K-numberK242453
Device nameTerragene® Bionova® Photon Process Challenge Device with unique-point integrator (PCD225-2);Terragene® Bionova® Photon Process Challenge Device with moving-front integrator (PCD225-C)
ApplicantTerragene S.A.
Product codeFRC
Device classClass II
Decision dateDec 12, 2024
DecisionSubstantially Equivalent
Regulation880.2800
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Terragene® Bionova® Photon Process Challenge Devices (PCD225-2 and PCD225-C) are disposable, pre-assembled packages containing a self-contained biological indicator with Geobacillus stearothermophilus spores, a chemical integrator, and a record card. They are designed to provide a defined challenge resistance equivalent to a 16-towel test pack and are intended for routine monitoring of steam sterilization processes at specified temperature and exposure time combinations. The devices are read using the Terragene® Bionova® Photon Auto-reader Incubator (BPH), which provides a 7-second fluorescent readout after 60°C incubation.

Technological characteristics

The subject devices differ from the predicate in three key areas: (1) they contain a newer Bionova® Photon Biological Indicator (BT225) with indirect growth detection using a non-enzymatic fluorophore (ANS binding to spore proteins) instead of the predicate's enzymatic α-glucosidase mechanism; (2) they have a shorter readout time of 7 seconds versus 20 minutes in the predicate; (3) they are used with a different auto-reader incubator (BPH). Both use identical chemical integrators, spore strains (10⁶ Geobacillus stearothermophilus), incubation temperature (60 ± 2°C), and biological resistance characteristics.

Test standards cited

FDA Guidance for Industry on Biological Indicator (BI) Premarket Notification [510(k)] Submissions (October 4, 2007); FDA Guidance on Chemical Indicators [510(k)] Submissions (December 19, 2003); ISO 11140-1:2014 (chemical and biological indicators classification); ANSI/AAMI ST79:2017 (comprehensive guide to steam sterilization and sterility assurance).

Substantial equivalence argument

The devices are substantially equivalent because they maintain identical intended use (routine steam sterilization monitoring), identical resistance characteristics and spore population to the predicate, and equivalent performance in the same claimed sterilization cycles. Although the biological indicator uses a different fluorophore mechanism and shorter readout time with a different incubator, comparative performance testing demonstrated that the Photon devices provide equivalent challenge resistance to both standalone indicators and the AAMI 16-towel reference pack, and perform identically to the predicate devices (PCD224-2 and PCD224-C) in all claimed cycles. The differences are technological improvements that do not affect the safety or effectiveness of the device for its intended purpose.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →